| UHC Surest Medical and Drug | Minimally Invasive Procedures for Gastric and Esophageal Diseases - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Motorized Spinal Traction – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Negative Pressure Wound Therapy – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Nerve Graft to Restore Erectile Function During Radical Prostatectomy – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Neurophysiologic Testing and Monitoring – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Obstructive and Central Sleep Apnea Treatment – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Occipital Nerve Injections and Ablation (Including Occipital Neuralgia and Headache) – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Ocrevus® (Ocrelizumab) and Ocrevus Zunovo® (Ocrelizumab and Hyaluronidase-Ocsq) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Orthognathic (Jaw) Surgery – Commercial and Individual Exchange Medical Policy | 2026-01-01 |